Jorge Leon-Cruz

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Harvard University(Current)

Cancer Research And Biostatistics

Icahn School of Medicine at Mount Sinai

Massachusetts General Hospital

Duke University

Jorge Leon-Cruz is an author at Harvard University specializing in antiretroviral therapy, hiv prevention, and human immunodeficiency virus pharmacotherapy.

Publications per year

2018–2023

Publications

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

Steven Grinspoon, Kathleen V. Fitch, Markella V. Zanni et al. · New England Journal of Medicine · 2023 · 455 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +10

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

Susan Swindells, Ritesh Ramchandani, Amita Gupta et al. · New England Journal of Medicine · 2019 · 370 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298

Timothy Wilkin, Huichao Chen, Michelle Cespedes et al. · Clinical Infectious Diseases · 2018 · 139 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV

Jordan E. Lake, Jana Taron, Heather J. Ribaudo et al. · AIDS · 2023 · 17 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +17

Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention

Anthony T. Podany, Jorge Leon-Cruz, James Hakim et al. · Journal of Antimicrobial Chemotherapy · 2020 · 16 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–5 of 6